Corrigendum to Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer (eBioMedicine (2018) 38 (100–112), (S2352396418304973), (10.1016/j.ebiom.2018.11.004))

Pinar Kanlikilicer, Recep Bayraktar, Merve Denizli, Mohammed H. Rashed, Cristina Ivan, Burcu Aslan, Rahul Mitra, Kubra Karagoz, Emine Bayraktar, Xinna Zhang, Cristian Rodriguez-Aguayo, Amr Ahmed El-Arabey, Nermin Kahraman, Seyda Baydogan, Ozgur Ozkayar, Michael L. Gatza, Bulent Ozpolat, George A. Calin, Anil K. Sood, Gabriel Lopez-Berestein

Research output: Contribution to journalComment/debatepeer-review

Abstract

In our recent publication titled “Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer” published in Ebiomedicine, Volume 38, Page 100–112, Dec 2018, an error in Figure 3e with beta-actin bands was identified. The unintentional error occurred due to an orientation issue with the film development of the beta-actin bands. Specifically, during the detection of Western blot beta-actin signal, first exposure of the membrane gave us strong signals with overexposed bands. We used the bottom part of the same X-ray film for the development of second exposure without being in contact with one another. Second exposure was taken up-side down orientation on the same X-ray film ensuring there is no contact with the first exposed view of the beta-actin bands. However, opposite orientation of the bands on the second exposure led to misinterpretation of the bands and beta-actin bands for Figure 3e were not taken appropriately for the samples labeled. We apologize for any confusion or inconvenience this may have caused. We have since re-evaluated the results using the original uncropped X-ray images, and corrected the figure, containing the appropriate beta-actin bands from the first exposure, is provided below.[Formula presented] We are committed to upholding the highest standards of scientific accuracy and transparency, and we have implemented additional checks in our processes to prevent similar errors in future work. We sincerely apologize for any inconvenience this error may have caused and appreciate the understanding and continued support of the scientific community.

Original languageEnglish (US)
Article number105486
JournalEBioMedicine
Volume111
DOIs
StatePublished - Jan 2025

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Corrigendum to Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer (eBioMedicine (2018) 38 (100–112), (S2352396418304973), (10.1016/j.ebiom.2018.11.004))'. Together they form a unique fingerprint.

Cite this